Aevi Genomic Medicine, LLC Aktie London S.E.

Aktien

Verzögert London S.E. Andere Börsenplätze			% 5 Tage	% 1. Jan.
- ^GBX	-.--%		-7,63 %	-.--%

Dauer

Zeitraum

Stil

Medgenics, Inc. : Medgenics Receives Orphan Drug Designation from FDA for INFRADURE Biopump to Treat Hepatitis D	20.06.12
Medgenics, Inc. : Medgenics to Present at the 11th Annual ILSI BIOMED 2012	18.05.12
Medgenics, Inc. : Medgenics Announces First Quarter 2012 Financial Results	14.05.12
Medgenics, Inc. : Medgenics Awarded $2.2 Million Grant from the Israeli Office of the Chief Scientist	09.05.12
Medgenics, Inc. : Medgenics Comments on Market Trading Activity	26.04.12

Sektor